Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2765 (LINC02765) is a long non-coding RNA (lncRNA) gene that does not code for a protein and is classified as a long intergenic non-coding RNA (lincRNA)[1][5][7]. LincRNAs are transcripts longer than 200 nucleotides, positioned in the genome between protein-coding genes, and typically serve regulatory functions, particularly in gene expression[5][7]. The functions of specific lincRNAs like LINC02765 are often uncharacterized, though lincRNAs in general have been shown to influence transcriptional and post-transcriptional regulation, chromatin modification, and the activity of nearby genes[3][5][7]. There is currently no evidence that LINC02765 acts as a receptor, enzyme, transporter, or direct therapeutic target[1], nor is there any reported interaction with approved drugs, specific mechanism of drug interaction, established biomarker application, or disease association for LINC02765 specifically.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2765 (LINC02765).